Katy Bradford: Cassette approach offers compelling construction solution
Filter News
Area of Research
- (-) Isotopes (2)
- (-) Materials for Computing (7)
- (-) Nuclear Science and Technology (13)
- Advanced Manufacturing (2)
- Biology and Environment (14)
- Clean Energy (57)
- Computational Biology (1)
- Computational Engineering (1)
- Fusion and Fission (12)
- Fusion Energy (11)
- Materials (44)
- National Security (6)
- Neutron Science (63)
- Nuclear Systems Modeling, Simulation and Validation (1)
- Supercomputing (19)
- Transportation Systems (2)
News Type
News Topics
- (-) Advanced Reactors (6)
- (-) Biomedical (6)
- (-) Fusion (2)
- (-) Molten Salt (3)
- (-) Neutron Science (6)
- (-) Transformational Challenge Reactor (1)
- (-) Transportation (3)
- 3-D Printing/Advanced Manufacturing (6)
- Bioenergy (1)
- Chemical Sciences (3)
- Climate Change (1)
- Composites (1)
- Computer Science (4)
- Coronavirus (2)
- Decarbonization (1)
- Energy Storage (3)
- Environment (2)
- Irradiation (1)
- Isotopes (12)
- Materials (10)
- Materials Science (12)
- Microscopy (3)
- Nanotechnology (4)
- National Security (1)
- Nuclear Energy (18)
- Physics (1)
- Polymers (5)
- Quantum Science (2)
- Security (1)
- Space Exploration (6)
- Summit (1)
- Sustainable Energy (5)
Media Contacts
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
After more than a year of operation at the Department of Energy’s (DOE’s) Oak Ridge National Laboratory (ORNL), the COHERENT experiment, using the world’s smallest neutrino detector, has found a big fingerprint of the elusive, electrically neutral particles that interact only weakly with matter.